Bora CDMO Bora CDMO

X

Find Naloxegol Oxalate manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

0

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

Naloxegol Oxalate
Also known as: 1354744-91-4, Nktr-118 oxalate, Naloxegol (oxalate), Naloxegol oxalate [usan], Az13337019 oxalate, Az-13337019 oxalate
Molecular Formula
C36H55NO15
Molecular Weight
741.8  g/mol
InChI Key
MNYIRXLCPODKLG-VUTNLTPYSA-N
FDA UNII
65I14TNM33

1 2D Structure

Naloxegol Oxalate

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(4R,4aS,7S,7aR,12bS)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;oxalic acid
2.1.2 InChI
InChI=1S/C34H53NO11.C2H2O4/c1-3-9-35-10-8-33-30-26-4-5-27(36)31(30)46-32(33)28(6-7-34(33,37)29(35)25-26)45-24-23-44-22-21-43-20-19-42-18-17-41-16-15-40-14-13-39-12-11-38-2;3-1(4)2(5)6/h3-5,28-29,32,36-37H,1,6-25H2,2H3;(H,3,4)(H,5,6)/t28-,29+,32-,33-,34+;/m0./s1
2.1.3 InChI Key
MNYIRXLCPODKLG-VUTNLTPYSA-N
2.1.4 Canonical SMILES
COCCOCCOCCOCCOCCOCCOCCOC1CCC2(C3CC4=C5C2(C1OC5=C(C=C4)O)CCN3CC=C)O.C(=O)(C(=O)O)O
2.1.5 Isomeric SMILES
COCCOCCOCCOCCOCCOCCOCCO[C@H]1CC[C@]2([C@H]3CC4=C5[C@]2([C@H]1OC5=C(C=C4)O)CCN3CC=C)O.C(=O)(C(=O)O)O
2.2 Other Identifiers
2.2.1 UNII
65I14TNM33
2.3 Synonyms
2.3.1 Depositor-Supplied Synonyms

1. 1354744-91-4

2. Nktr-118 Oxalate

3. Naloxegol (oxalate)

4. Naloxegol Oxalate [usan]

5. Az13337019 Oxalate

6. Az-13337019 Oxalate

7. 65i14tnm33

8. Moventig

9. (4r,4as,7s,7ar,12bs)-7-[2-[2-[2-[2-[2-[2-(2-methoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]-3-prop-2-enyl-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol;oxalic Acid

10. Naloxegol Oxalate (usan)

11. Unii-65i14tnm33

12. Movantik (tn)

13. Moventig (tn)

14. Nktr-118-oxalate

15. Naloxegol Oxalate [mi]

16. Naloxegol Oxalate(nktr-118)

17. Chembl2219416

18. Schembl20839999

19. Hy-a0118a

20. Dtxsid50159395

21. Naloxegol Oxalate [who-dd]

22. Akos030526444

23. Cs-5349

24. Naloxegol Oxalate [orange Book]

25. Nktr-118;az-13337019 Oxalate

26. Ac-36031

27. Movantik Component Naloxegol Oxalate

28. Az 13337019

29. Naloxegol Oxalate Component Of Movantik

30. D10375

31. Q27263878

32. 4,5.alpha.-epoxy-6.alpha.-((3,6,7,12,15,18,21-heptaoxadocosyl)oxy)-17-(prop-2-enyl)morphinan-3,14-diol Hydrogen Ethanedioate

33. 4,5alpha-epoxy-6alpha-((3,6,7,12,15,18,21-heptaoxadocosyl)oxy)-17-(prop-2-enyl)morphinan-3,14-diol Hydrogen Ethanedioate

34. Morphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-, (5.alpha.,6.alpha.)-, Ethanedioate (1:1)

35. Morphinan-3,14-diol, 4,5-epoxy-6-(3,6,9,12,15,18,21-heptaoxadocos-1-yloxy)-17-(2-propen-1-yl)-, (5alpha,6alpha)-, Ethanedioate (1:1)

2.4 Create Date
2012-05-14
3 Chemical and Physical Properties
Molecular Weight 741.8 g/mol
Molecular Formula C36H55NO15
Hydrogen Bond Donor Count4
Hydrogen Bond Acceptor Count16
Rotatable Bond Count25
Exact Mass741.35717005 g/mol
Monoisotopic Mass741.35717005 g/mol
Topological Polar Surface Area201 Ų
Heavy Atom Count52
Formal Charge0
Complexity971
Isotope Atom Count0
Defined Atom Stereocenter Count5
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Indication

Treatment of opioid-induced constipation (OIC) in adult patients who have had an inadequate response to laxative(s).


5 Pharmacology and Biochemistry
5.1 FDA Pharmacological Classification
5.1.1 Pharmacological Classes
Opioid Antagonists [MoA]; Opioid Antagonist [EPC]
5.2 ATC Code

A06AH03


left grey arrow
right gray arrow
  • TABLET;ORAL - EQ 12.5MG BASE
  • TABLET;ORAL - EQ 25MG BASE
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY